Anastas JN,Moon RT.Wnt signalling pathways as therapeutic targets in cancer[J].Nat Rev Cancer,2013,13(1):11-26.
[3]
D’Arey P,Linder S.Molecular pathways:translational potential of deubiquitinases as drug targets[J].Clin Cancer Res,2014,20(15):3 908-3 914.
[4]
彭静,胡倩,刘卫平,等.USP9X在非小细胞肺癌中的表达及与临床病理特征的关系[J].四川大学学报:医学版,2015,46(3):413-416.Peng J,Hu Q,Liu WP,et al.Expression of USP9X in non-small cell lung cancer and its clinical significance[J].Journal of Sichuan University(Medical Science Edition),2015,46(3):413-416.
[5]
Xu J,Taya S,Kaibuchi K,et al.Spatinally and temporally specific expression in mouse hippocampus of USP9X,a ubiquitin-specific protease involved in synaptic development[J].Journal of Neuroscience Research,2005,80(1):47-55.
Trivigno D,Essmann F,Huber SM,et al.Deubiquitinase USP9Xconfers radioresistance through stabilization of Mcl-1[J].Neoplasia,2012,14:892-904.
[8]
Zhao M,Fu K,Guo LL,et al.Evaluation of T1-DCE MRI for the preoperative pathological evaluation of tumor grade of brain glomia[J].Chin J Lab Diagn,2016,20(1):42-44.
[9]
Zhao S,Ma YM,Huang XH.Trefoil factor 1elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signaling[J].Int J Clini Exp Pathol,2015,8(9):10 412-10 419.
[10]
Peng J,Hu Q,Liu W,et al.USP9Xexpression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma[J].Diagn Pathol,2013,8:177.
